These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 25847280)

  • 21. LC-MS-MS analysis of dietary supplements for N-ethyl-α-ethyl-phenethylamine (ETH), N, N-diethylphenethylamine and phenethylamine.
    ElSohly MA; Gul W
    J Anal Toxicol; 2014 Mar; 38(2):63-72. PubMed ID: 24344073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass spectrometric characterization of a biotechnologically produced full-length mechano growth factor (MGF) relevant for doping controls.
    Thevis M; Thomas A; Geyer H; Schänzer W
    Growth Horm IGF Res; 2014 Dec; 24(6):276-80. PubMed ID: 25466910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications and challenges in using LC-MS/MS assays for quantitative doping analysis.
    Wang Z; Lu J; Zhang Y; Tian Y; Yuan H; Xu Y
    Bioanalysis; 2016 Jun; 8(12):1307-22. PubMed ID: 27241820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry.
    Görgens C; Guddat S; Thomas A; Wachsmuth P; Orlovius AK; Sigmund G; Thevis M; Schänzer W
    J Pharm Biomed Anal; 2016 Nov; 131():482-496. PubMed ID: 27693991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N,N-dimethyl-2-phenylpropan-1-amine quantification in urine: application to excretion study following single oral dietary supplement dose.
    Wójtowicz M; Jarek A; Chajewska K; Kwiatkowska D
    Anal Bioanal Chem; 2016 Jul; 408(18):5041-7. PubMed ID: 27178556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening and confirmation of a glycerol-positive case.
    Deventer K; Van Eenoo P
    Drug Test Anal; 2015; 7(11-12):1009-13. PubMed ID: 26695488
    [No Abstract]   [Full Text] [Related]  

  • 29. Liquid chromatography-tandem mass spectrometry screening method for the simultaneous detection of stimulants and diuretics in urine.
    Hsu KF; Chien KY; Chang-Chien GP; Lin SF; Hsu PH; Hsu MC
    J Anal Toxicol; 2011 Nov; 35(9):665-74. PubMed ID: 22080905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unraveling the complexity of anti-doping analysis: reassessing meldonium detection and doping verdicts in a case study.
    Cristoni S; Vitarelli F; Spiti S; Brambilla M; Larini M; Calabrone L; Brogna C; Malvandi AM; Conti M; Puccio G; Donato K; Beccari T; Bertelli M; Leoni V
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(6 Suppl):114-118. PubMed ID: 38112958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls.
    Thevis M; Möller I; Thomas A; Beuck S; Rodchenkov G; Bornatsch W; Geyer H; Schänzer W
    Anal Bioanal Chem; 2010 Apr; 396(7):2479-91. PubMed ID: 19946680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a ultra high performance liquid chromatography-tandem mass spectrometric method for the direct detection of formoterol in human urine.
    Sardela VF; Deventer K; Pereira HM; de Aquino Neto FR; Van Eenoo P
    J Pharm Biomed Anal; 2012 Nov; 70():471-5. PubMed ID: 22841556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.
    Thomas A; Höppner S; Geyer H; Schänzer W; Petrou M; Kwiatkowska D; Pokrywka A; Thevis M
    Anal Bioanal Chem; 2011 Aug; 401(2):507-16. PubMed ID: 21298258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls.
    Eichner D; Van Wagoner RM; Brenner M; Chou J; Leigh S; Wright LR; Flippin LA; Martinelli M; Krug O; Schänzer W; Thevis M
    Drug Test Anal; 2017 Nov; 9(11-12):1768-1778. PubMed ID: 28378453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A one-year monitoring of nicotine use in sport: frontier between potential performance enhancement and addiction issues.
    Marclay F; Grata E; Perrenoud L; Saugy M
    Forensic Sci Int; 2011 Dec; 213(1-3):73-84. PubMed ID: 21719221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of mildronate in human plasma and urine by liquid chromatography-tandem mass spectrometry.
    Lv YF; Hu X; Bi KS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):35-9. PubMed ID: 17287154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
    Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-dimensional gas chromatography with heart-cutting for isotope ratio mass spectrometry analysis of steroids in doping control.
    Brailsford AD; Gavrilović I; Ansell RJ; Cowan DA; Kicman AT
    Drug Test Anal; 2012 Dec; 4(12):962-9. PubMed ID: 22761127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbon isotope ratio analysis of endogenous glucocorticoid urinary metabolites after cortisone acetate and adrenosterone administration for doping control.
    Brooker L; Cawley A; Kazlauskas R; Goebel C; George A
    Drug Test Anal; 2012 Dec; 4(12):951-61. PubMed ID: 22987608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples.
    Hullstein IR; Malerod-Fjeld H; Dehnes Y; Hemmersbach P
    Drug Test Anal; 2015; 7(11-12):1025-9. PubMed ID: 26607218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.